524516
BACPHAR
Start SIP
Invest Now
Start SIP in BACPHAR
Performance
- Low
- ₹40
- High
- ₹42
- 52 Week Low
- ₹27
- 52 Week High
- ₹50
- Open Price₹42
- Previous Close₹40
- Volume22,737
Investment Returns
- Over 1 Month + 2.88%
- Over 3 Month -5.41%
- Over 6 Month + 17.79%
- Over 1 Year -17.57%
Smart Investing Starts Here Start SIP with Bacil Pharma for Steady Growth!
Bacil Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 95.1
- PEG Ratio
- 1.5
- Market Cap Cr
- 61
- P/B Ratio
- 2.3
- Average True Range
- 2.71
- EPS
- -
- Dividend Yield
- 0
- MACD Signal
- -0.35
- RSI
- 63.7
- MFI
- 58.61
Bacil Pharma Financials
Bacil Pharma Technicals
EMA & SMA
Current Price
₹42.17
+
1.92
(4.77%)
- Bearish Moving Average 1
- Bullish Moving Average 15
- 20 Day
- ₹37.46
- 50 Day
- ₹37.62
- 100 Day
- ₹38.35
- 200 Day
- ₹37.50
Resistance and Support
41.51
- R3 45.08
- R2 43.67
- R1 42.92
- S1 40.76
- S2 39.35
- S3 38.60
Bacil Pharma Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-13 | Quarterly Results | |
| 2025-09-05 | Others | Inter-alia, to consider 1. Fix Date, Place, Timing and Notice for 38th AGM of the Company. 2. Director Report of the Company for the Financial Year 2024-2025. 3. Other business matters. |
| 2025-08-25 | Others | Inter-alia, to consider 1. Discussion on Appointment of M/s Sarang Shivajirao Chavan & Associate as a Statutory Auditor of the Company. 2. Appointment of New Director. 3. Other business matters. |
| 2025-08-12 | Quarterly Results | |
| 2025-07-16 | Others | Inter-alia, to consider 1. Appointment of a new Executive Director and Chief Financial Officer of the Company. 2. Resignation of the present Chief Financial Officer. 3. Other business matters. |
Bacil Pharma F&O
About Bacil Pharma
- NSE Symbol
- BACPHAR
- BSE Symbol
- 524516
- ISIN
- INE711D01018
Similar Stocks to Bacil Pharma
Bacil Pharma FAQs
Bacil Pharma share price is ₹42 As on 07 January, 2026 | 04:51
The Market Cap of Bacil Pharma is ₹60.5 Cr As on 07 January, 2026 | 04:51
The P/E ratio of Bacil Pharma is 95.1 As on 07 January, 2026 | 04:51
The PB ratio of Bacil Pharma is 2.3 As on 07 January, 2026 | 04:51
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.